Is It Safe to Take Ritonavir and Simvastatin Together?
Ritonavir and simvastatin are contraindicated together due to serious risk of myopathy and rhabdomyolysis. Learn why this combination is ...
No—naproxen and warfarin together create a major interaction that significantly increases the risk of serious bleeding. The two drugs have a synergistic effect on bleeding, meaning they work together in a way that amplifies the danger beyond what either drug poses alone. This combination should be avoided unless explicitly approved and closely monitored by your prescribing physician and pharmacist.
According to U.S. FDA drug labeling data, naproxen and warfarin carry a major severity interaction classification. The documented interaction description is straightforward: "Naproxen and warfarin have synergistic effect on bleeding with increased risk of serious bleeding compared to either drug alone." This record was last updated in May 2026 and is sourced from FDA-maintained drug labeling information (NLP: naproxen).
The sourcing authority here is the same system used by the U.S. Food and Drug Administration to label medications for clinical use. When the FDA documentation flags an interaction as "major," it means that the combination poses a clinically significant risk that requires careful evaluation before use.
To understand why this combination is dangerous, it helps to know what each drug does:
Warfarin is an anticoagulant—a medication that reduces the blood's ability to clot. Patients take warfarin to prevent unwanted blood clots that could cause stroke, heart attack, or other serious events. Warfarin works by blocking vitamin K-dependent clotting factors in the liver, making the blood thinner and slower to clot.
Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). People use naproxen to reduce pain, fever, and inflammation. NSAIDs like naproxen work by blocking inflammatory signaling in the body—but they do this partly by affecting the stomach lining, platelet function, and blood vessel integrity.
The documented interaction mechanism is synergistic effect on bleeding. This means that when naproxen is combined with warfarin, the risk of bleeding is greater than what you would expect if you simply added the individual risks of each drug together. The two mechanisms converge to create a compounded hazard.
To illustrate why, consider some general background: NSAIDs like naproxen can cause gastrointestinal irritation and ulceration, which may bleed on their own. They also reduce platelet stickiness—the ability of blood cells to clump together and form a clot. When you also take warfarin, which already slows clotting throughout the whole body, these effects layer on top of each other. The result is a much higher chance of bleeding in the stomach, elsewhere in the gastrointestinal tract, or elsewhere in the body.
The FDA documentation does not specify additional mechanistic details beyond the synergistic bleeding effect. The key clinical point is that this is a documented interaction—it is not theoretical speculation but an observed, recorded warning based on drug labeling safety data.
Anyone taking warfarin should be alert to this interaction. Warfarin is prescribed for several common conditions: atrial fibrillation (a heart rhythm disorder), venous thromboembolism (blood clots in the veins), and certain mechanical heart valves. People with these conditions often also experience pain or inflammation and may reach for naproxen without realizing the danger.
The combination is especially risky because:
However, the documented interaction applies to the drug pair itself, regardless of patient age or condition. If you are taking warfarin, you should assume naproxen poses this major risk unless your physician has specifically discussed an exception.
Scenario 1 (Documented Risk): A patient with atrial fibrillation has been taking warfarin for two years to prevent stroke. On a weekend, they develop a headache and muscle soreness and decide to take naproxen for pain relief. Over the next few days, they notice some black or tarry stools—a sign of bleeding in the upper gastrointestinal tract. The combined effect of warfarin's anticoagulation and naproxen's platelet and stomach-lining effects has triggered bleeding. This is the kind of serious adverse event the FDA documented interaction is meant to flag.
Scenario 2 (Appropriate Alternative): The same patient with atrial fibrillation develops a headache. Before taking any over-the-counter pain relief, they check their medication list or ask their pharmacist. The pharmacist explains the naproxen-warfarin interaction and suggests acetaminophen instead, which does not carry the same bleeding risk with warfarin. The patient takes acetaminophen, the pain subsides, and no bleeding occurs. This is how source-aware medicine works in practice.
If you are taking warfarin and experience pain, inflammation, or fever, do not assume over-the-counter pain relievers are safe. Instead, bring the following questions to your pharmacist or physician:
Remember: your pharmacist and physician are your partners in preventing this interaction. They have access to your complete medication history and can give you personalized guidance. If you have already taken naproxen while on warfarin, do not panic—talk to your pharmacist or doctor about whether monitoring is needed. Do not stop either medication on your own.
Every person taking warfarin should be aware of drug interactions that could increase bleeding risk. If you are currently taking both naproxen and warfarin, or if you take warfarin and are considering any pain reliever, take action now: visit checkdruginteractions.com to check your full medication list for documented interactions. Then confirm your medication choices with your pharmacist or physician. Your safety depends on informed decisions made in partnership with your healthcare team.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Ritonavir and simvastatin are contraindicated together due to serious risk of myopathy and rhabdomyolysis. Learn why this combination is ...
FDA-documented interaction between atorvastatin and clarithromycin. Learn severity, mechanism, and what to discuss with your pharmacist.
A documented moderate interaction exists between valproic acid and lamotrigine. Learn what it means and what to discuss with your doctor.